Frataxin deficiency impairs mitochondrial biogenesis in cells, mice and humans

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Human Molecular Genetics

• Publication date

  2017-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddx141PMID 28444186PMCID PMC6251520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma circulating cell-free mitochondrial DNA in the assessment of Friedreich's ataxia.

  2016cited by this paper
• Frataxin Deficiency Promotes Excess Microglial DNA Damage and Inflammation that Is Rescued by PJ34

  2016cited by this paper
• Deep sequencing of mitochondrial genomes reveals increased mutation load in Friedreich's ataxia

  2016cited by this paper
• Investigation of mitochondrial DNA variations among Indian Friedreich's ataxia (FRDA) patients.

  2015cited by this paper
• Gene Expression Profiling of Mitochondrial Oxidative Phosphorylation (OXPHOS) Complex I in Friedreich Ataxia (FRDA) Patients

  2014cited by this paper
• Animal and cellular models of Friedreich ataxia

  2013cited by this paper
• Clinical features of Friedreich's ataxia: classical and atypical phenotypes

  2013cited by this paper
• Mitochondrial pathophysiology in Friedreich's ataxia

  2013cited by this paper
• Frataxin Deficiency Leads to Defects in Expression of Antioxidants and Nrf2 Expression in Dorsal Root Ganglia of the Friedreich's Ataxia YG8R Mouse Model

  2013cited by this paper
• Prevalence gradients of Friedreich's Ataxia and R1b haplotype in Europe co‐localize, suggesting a common Palaeolithic origin in the Franco‐Cantabrian ice age refuge

  2013cited by this paper
• Treatment of Friedreich's ataxia

  2013cited by this paper
• A Chemical Screen Probing the Relationship between Mitochondrial Content and Cell Size

  2012cited by this paper
• Differential Expression of PGC-1α and Metabolic Sensors Suggest Age-Dependent Induction of Mitochondrial Biogenesis in Friedreich Ataxia Fibroblasts

  2011cited by this paper
• Altered Gene Expression and DNA Damage in Peripheral Blood Cells from Friedreich's Ataxia Patients: Cellular Model of Pathology

  2010cited by this paper
• PGC-1alpha Down-Regulation Affects the Antioxidant Response in Friedreich's Ataxia

  2010cited by this paper
• A Novel Mitochondrial Heteroplasmic C13806A Point Mutation Associated with Iranian Friedreich’s Ataxia

  2009cited by this paper
• Mitochondrial Dysfunction in Neurodegenerative Diseases

  2008cited by this paper
• Frataxin knockdown causes loss of cytoplasmic iron-sulfur cluster functions, redox alterations and induction of heme transcripts.

  2007cited by this paper
• Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones.

  2007cited by this paper
• Identification and sizing of GAA trinucleotide repeat expansion, investigation for D-loop variations and mitochondrial deletions in Iranian patients with Friedreich's ataxia.

  2006cited by this paper
• Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

  2006cited by this paper
• Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

  2005cited by this paper
• Impairing the bioenergetic status and the biogenesis of mitochondria triggers mitophagy in yeast

  2005cited by this paper
• Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits

  2001cited by this paper
• Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia.

  2000cited by this paper
• The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis.

  1999cited by this paper
• Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.

  1999cited by this paper
• Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin

  1997cited by this paper
• Aconitase and mitochondrial iron–sulphur protein deficiency in Friedreich ataxia

  1997cited by this paper
• Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion

  1996cited by this paper

• Ketosis rescues frataxin deficiency and corrects disease phenotypes in an FRDA animal model

  2026cites this paper
• Effect of Chronic Stress on Whole Blood Transcriptome: A Meta-Analysis of Publicly Available Datasets from Rodent Models

  2025cites this paper
• Leriglitazone improves iron homeostasis and ferroptotic markers in frataxin-deficient dorsal root ganglia neurons.

  2025cites this paper
• Therapeutic combination of L-ascorbic acid, N-acetylcysteine, and dimethyl fumarate in Friedreich’s ataxia: insights from in vitro models

  2025cites this paper
• Phenothiazines: Nrf2 activation and antioxidant effects

  2024cites this paper
• Monogenic Disorders of ROS Production and the Primary Anti-Oxidative Defense

  2024cites this paper
• Emerging antioxidant therapies in Friedreich’s ataxia

  2024cites this paper
• Adenosine Improves Mitochondrial Function and Biogenesis in Friedreich’s Ataxia Fibroblasts Following L-Buthionine Sulfoximine-Induced Oxidative Stress

  2023cites this paper
• Mitochondrial Inherited Disorders and their Correlation with Neurodegenerative Diseases.

  2023cites this paper
• Apparent Opportunities and Hidden Pitfalls: The Conflicting Results of Restoring NRF2-Regulated Redox Metabolism in Friedreich’s Ataxia Pre-Clinical Models and Clinical Trials

  2023cites this paper
• Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia

  2022cites this paper
• Frataxin controls ketone body metabolism through regulation of OXCT1

  2022cites this paper
• Discovery of Therapeutics Targeting Oxidative Stress in Autosomal Recessive Cerebellar Ataxia: A Systematic Review

  2022cites this paper
• A Drug Combination Rescues Frataxin-Dependent Neural and Cardiac Pathophysiology in FA Models

  2022influential citation
• Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids.

  2022cites this paper
• Acute frataxin knockdown in induced pluripotent stem cell-derived cardiomyocytes activates a type I interferon response

  2022cites this paper
• Efficacy and Safety of Leriglitazone in Patients With Friedreich Ataxia

  2022cites this paper
• Nuclear Factor Erythroid-2-Related Factor 2 Signaling in the Neuropathophysiology of Inherited Metabolic Disorders

  2021cites this paper
• Mitochondrial and metabolic dysfunction in Friedreich ataxia: update on pathophysiological relevance and clinical interventions

  2021cites this paper
• Treatment with ROS detoxifying gold quantum clusters alleviates the functional decline in a mouse model of Friedreich ataxia

  2021cites this paper
• Neuroinflammation in the Cerebellum and Brainstem in Friedreich Ataxia: An [18F]‐FEMPA PET Study

  2021cites this paper
• Thioredoxin and Glutaredoxin Systems as Potential Targets for the Development of New Treatments in Friedreich’s Ataxia

  2020cites this paper
• The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich’s Ataxia

  2020cites this paper
• Oxidative Stress, a Crossroad between Rare Diseases and Neurodegeneration

  2020cites this paper
• CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich’s Ataxia

  2020cites this paper
• Antioxidant Therapies and Oxidative Stress in Friedreich’s Ataxia: The Right Path or Just a Diversion?

  2020cites this paper
• Frataxin gene editing rescues Friedreich’s ataxia pathology in dorsal root ganglia organoid-derived sensory neurons

  2020cites this paper
• PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.

  2020cites this paper
• Mitochondrial dysfunction in the development and progression of neurodegenerative diseases.

  2020cites this paper
• Dimethyl fumarate dose-dependently increases mitochondrial gene expression and function in muscle and brain of Friedreich's ataxia model mice.

  2020cites this paper
• Safety and feasibility of upper limb cardiopulmonary exercise test in Friedreich ataxia.

  2020cites this paper
• Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia

  2020cites this paper
• Assessment of cell-free levels of iron and copper in patients with Friedreich’s ataxia

  2019cites this paper
• Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich’s Ataxia Mouse Model

  2019cites this paper
• Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia

  2019influential citation
• Potential biomarker identification for Friedreich’s ataxia using overlapping gene expression patterns in patient cells and mouse dorsal root ganglion

  2019influential citation
• Ironing the mitochondria: Relevance to its dynamics.

  2019cites this paper
• Friedreich ataxia- pathogenesis and implications for therapies.

  2019cites this paper
• Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer.

  2019cites this paper
• Iron regulatory protein 2 modulates the switch from aerobic glycolysis to oxidative phosphorylation in mouse embryonic fibroblasts

  2019cites this paper
• Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?

  2019cites this paper
• Dynamics of Iron Homeostasis in Health and Disease: Molecular Mechanisms and Methods for Iron Determination

  2019cites this paper
• Effects of tocotrienol supplementation in Friedreich's ataxia: A model of oxidative stress pathology.

  2019cites this paper
• Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects

  2018cites this paper
• Role of frataxin protein deficiency and metabolic dysfunction in Friedreich ataxia, an autosomal recessive mitochondrial disease

  2018cites this paper
• GRP75 overexpression rescues frataxin deficiency and mitochondrial phenotypes in Friedreich ataxia cellular models.

  2018cites this paper
• Phenothiazine antioxidants increase mitochondrial biogenesis and frataxin levels in Friedreich's ataxia cells.

  2018cites this paper
• Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.

  2018cites this paper
• Early cerebellar deficits in mitochondrial biogenesis and respiratory chain complexes in the KIKO mouse model of Friedreich ataxia

  2017influential citation